Compare Stocks

→ Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APHB Ampliphi Biosciences	$2.50 -1.2%	$0.00	$0.15 ▼ $1.37	$83.67M	N/A	842,200 shs	4,871 shs
EMH Emerald Health Therapeutics	C$0.26 -3.8%	C$0.26	C$0.15 ▼ C$0.53	C$52.28M	N/A	644,760 shs	384,329 shs

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EMH Emerald Health Therapeutics	0.00%	0.00%	0.00%	0.00%	0.00%

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
APHB Ampliphi Biosciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EMH Emerald Health Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
APHB Ampliphi Biosciences	N/A	N/A	N/A	N/A
EMH Emerald Health Therapeutics	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
APHB Ampliphi Biosciences	N/A	N/A	N/A	N/A	N/A	N/A
EMH Emerald Health Therapeutics	C$13.02M	4.02	C$0.33 per share	0.78	C$0.40 per share	0.64

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
APHB Ampliphi Biosciences	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
EMH Emerald Health Therapeutics	N/A	-C$0.70	N/A	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
APHB Ampliphi Biosciences	N/A	N/A	N/A	N/A	N/A
EMH Emerald Health Therapeutics	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
APHB Ampliphi Biosciences	N/A	N/A	N/A
EMH Emerald Health Therapeutics	35.45	2.97	2.61

Ownership

Institutional Ownership

Company	Institutional Ownership
APHB Ampliphi Biosciences	N/A
EMH Emerald Health Therapeutics	N/A

Insider Ownership

Company	Insider Ownership
APHB Ampliphi Biosciences	N/A
EMH Emerald Health Therapeutics	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
APHB Ampliphi Biosciences	30	33.47 million	N/A	Not Optionable
EMH Emerald Health Therapeutics	161	205.03 million	N/A	Not Optionable

APHB, MDG1, EMH, and ARIX Headlines

Source	Headline
	University Hospitals Elyria Medical Center health.usnews.com - September 23 at 12:26 AM
	Digital Therapeutics: Next wave in managing chronic medical conditions health.economictimes.indiatimes.com - September 13 at 9:19 PM
	The Digital Therapeutics Market Is Gangbusters mddionline.com - August 29 at 11:45 PM
	Digital Therapeutics (DTx) For Mental Health Market is Booming and Expected to Grow at a CAGR of 27.42% to 2031 \| InsightAce Study finance.yahoo.com - July 31 at 12:17 AM
	Emerald Isle’s Lee Avenue to close again soon as culvert project restarts carolinacoastonline.com - July 15 at 8:44 AM
	Efficient Market Hypothesis (EMH): Definition and Critique investopedia.com - July 12 at 2:56 PM
	Revolutionizing mental health treatment: Vistagen Therapeutics' nasal spray solution finance.yahoo.com - June 20 at 12:36 PM
	Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023 thaipr.net - May 29 at 4:23 AM
	Emerald Care Center Tulsa health.usnews.com - May 4 at 11:26 PM
	Emerald Reeg health.usnews.com - April 25 at 7:35 AM
	Emerald Expositions GAAP EPS of $0.06, revenue of $93.6M msn.com - March 14 at 9:07 AM
	Tahoe's Emerald Bay freezes over for first time in decades amid atmospheric river sfgate.com - March 13 at 4:02 AM
	Visus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care Conference venturebeat.com - March 4 at 6:25 PM
	Emerald community raising money for local dialysis services after political campaigns fail abc.net.au - February 25 at 12:07 AM
	New Digital Therapeutics Company Takes a 'Swing' at Fibromyalgia mddionline.com - February 22 at 11:25 PM
	Emerald Asset Management PA, LLC 30th Annual Emerald Groundhog Day Investment Forum Opens Amid a Stormy 2023 Investment Year finance.yahoo.com - January 14 at 1:43 PM
	Emerald Health Therapeutics Inc (TBD.BE) finance.yahoo.com - January 4 at 3:42 AM
	Emerald Health Therapeutics Announces Revocation of Management Cease Trade Order finance.yahoo.com - July 12 at 9:36 AM
	Emerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Update finance.dailyherald.com - July 4 at 7:56 AM
	Emerald Health Therapeutics Provides Bi-Weekly MCTO Status Update finance.yahoo.com - June 16 at 8:02 AM
	Emerald Health Therapeutics, Inc. Provides Bi-Weekly MCTO Status Update stockhouse.com - May 16 at 4:37 PM
	Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics nz.finance.yahoo.com - May 12 at 9:26 AM
	Cannabis Stock News: Emerald Health Therapeutics, Inc. (CSE: EMH) Transfers US Listing to OTCQB investorideas.com - May 6 at 10:47 AM
	Emperor Oil Ltd (EMh) investing.com - January 5 at 8:00 AM

Media Sentiment Over Time

Company Descriptions

Ampliphi Biosciences

NYSEAMERICAN:APHB

AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P. aeruginosa) infections. It holds collaborative research and development agreements with the United States Army Medical Research and Materiel Command for the development of bacteriophage therapeutics to treat S. aureus, E. coli, and P. aeruginosa infections; and Walter Reed Army Institute of Research. The company was formerly known as Targeted Genetics Corporation and changed its name to AmpliPhi Biosciences Corporation in February 2011. AmpliPhi Biosciences Corporation was founded in 1989 and is headquartered in San Diego, California.

Emerald Health Therapeutics

CVE:EMH

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial